Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors Peer median
Gross Margin for LTGO and competitors
Company Period LTM level YoY 3-year change
PCRXPacira BioSciences, Inc.LTM Mar 202679.3% +1.7 pp+9.3 pp
COLLCollegium Pharmaceutical, Inc.LTM Mar 202660.7% +3.0 pp+14.2 pp
SCLXScilex Holding CompanyLTM Mar 202655.0% -17.0 pp-21.9 pp
LTGOLatigo Biotherapeutics Inc.—— ——
Peer median (excluding LTGO) 60.7%+1.7 pp+9.3 pp

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.